Literature DB >> 9531662

Ivermectin for Sarcoptes scabiei hyperinfestation.

S E Huffam1, B J Currie.   

Abstract

OBJECTIVES: Crusted (Norwegian) scabies is an unusual variant of scabies caused by hyperinfestation with Sarcoptes scabiei. It has high morbidity, and secondary bacterial skin sepsis may result in life-threatening bacteremia. An open label study of oral ivermectin was carried out in patients with crusted scabies refractory to topical therapy.
METHODS: Patients with refractory crusted scabies were prescribed oral ivermectin, one to three doses of 200 mg/kg at 14-day intervals, combined with topical scabicide and keratolytic therapy.
RESULTS: Of the 20 patients who received ivermectin, 8 had a complete initial clinical response, a partial response was achieved in 9, and minimal improvement occurred in 3. Three doses of ivermectin were curative for 8 of 10 cases, but recurrence of scabies from presumed reinfestation occurred in at least half of these.
CONCLUSION: The authors conclude that ivermectin is effective for crusted scabies; however, multiple doses may be required to achieve a cure, and recurrence 6 or more weeks after completing treatment is common.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9531662     DOI: 10.1016/s1201-9712(98)90118-7

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  15 in total

Review 1.  Treatment of scabies: newer perspectives.

Authors:  K Karthikeyan
Journal:  Postgrad Med J       Date:  2005-01       Impact factor: 2.401

2.  In Vitro Activity of Beauvericin against All Developmental Stages of Sarcoptes scabiei.

Authors:  Charbel Al Khoury; Nabil Nemer; Georges Nemer; Mazen Kurban; Charlotte Bernigaud; Katja Fischer; Jacques Guillot
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

3.  Unusual laboratory findings in a case of Norwegian scabies provided a clue to diagnosis.

Authors:  Samson S Y Wong; Patrick C Y Woo; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

Review 4.  Scabies: more than just an irritation.

Authors:  J S McCarthy; D J Kemp; S F Walton; B J Currie
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

Review 5.  Problems in diagnosing scabies, a global disease in human and animal populations.

Authors:  Shelley F Walton; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

6.  Calculation of the age of the first infection for skin sores and scabies in five remote communities in northern Australia.

Authors:  M J Lydeamore; P T Campbell; W Cuningham; R M Andrews; T Kearns; D Clucas; R Gundjirryirr Dhurrkay; J Carapetis; S Y C Tong; J M McCaw; J McVernon
Journal:  Epidemiol Infect       Date:  2018-05-08       Impact factor: 4.434

7.  Scabies: an ancient global disease with a need for new therapies.

Authors:  Jackson Thomas; Greg M Peterson; Shelley F Walton; Christine F Carson; Mark Naunton; Kavya E Baby
Journal:  BMC Infect Dis       Date:  2015-07-01       Impact factor: 3.090

8.  Impact of an Ivermectin Mass Drug Administration on Scabies Prevalence in a Remote Australian Aboriginal Community.

Authors:  Thérèse M Kearns; Richard Speare; Allen C Cheng; James McCarthy; Jonathan R Carapetis; Deborah C Holt; Bart J Currie; Wendy Page; Jennifer Shield; Roslyn Gundjirryirr; Leanne Bundhala; Eddie Mulholland; Mark Chatfield; Ross M Andrews
Journal:  PLoS Negl Trop Dis       Date:  2015-10-30

9.  A misdiagnosed infection mimicking "tree man disease".

Authors:  Jo Anne Lim; Zulrusydi Ismail; Che Noraini Ibrahim; Soon Eu Chong; Wan Noor Hasbee Wan Abdullah
Journal:  PLoS Negl Trop Dis       Date:  2017-06-15

10.  A novel clinical grading scale to guide the management of crusted scabies.

Authors:  Joshua S Davis; Steven McGloughlin; Steven Y C Tong; Shelley F Walton; Bart J Currie
Journal:  PLoS Negl Trop Dis       Date:  2013-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.